Suppr超能文献

中风后的生存--CHA2DS2-VASc 评分和心房颤动的影响。

Survival after stroke--the impact of CHADS2 score and atrial fibrillation.

机构信息

Department of Laboratory Medicine, Lund University, Lund, Sweden.

出版信息

Int J Cardiol. 2010 May 14;141(1):18-23. doi: 10.1016/j.ijcard.2008.11.122. Epub 2009 Jan 13.

Abstract

OBJECTIVE

This study examined all-cause mortality in stroke patients with and without documented atrial fibrillation (AF), and the impact of CHADS(2) score.

DESIGN

A cohort of 105,074 patients, 31,821 (30.3%) with and 73,253 (69.7%) without documented AF, was studied. These patients were registered in the Swedish Stroke Registry during the years 2001-2005. Mortality data were retrieved from the Swedish Cause of Death Register. CHADS(2) score prior to stroke were assessed using the Swedish National Discharge Register.

RESULTS

The age and sex adjusted relative risk (RR) of death was 1.46 (1.43-1.49) for AF vs non-AF patients. High age (>or=75 years) tripled the risk of death and was the single most important predictor, followed by congestive heart failure, previous stroke and diabetes. Less than half of the AF patients with a CHADS(2) score of 1-6 survived more than 5 years, whereas AF patients with a CHADS(2) score of 0 had a 73% chance of survival. In patients with AF, the relative risk of death was 6.05 (CI: 2.26-6.95); in subjects with the highest vs the lowest CHADS(2) score; the corresponding RR for non-AF patients was 7.93 (CI: 7.01-8.97).

CONCLUSIONS

The CHADS(2) score seems to have an impact on all-cause mortality after stroke. The CHADS(2) score can give valuable insight for other outcome variables apart from having had an ischemic stroke and can be applied to patients with different risk factor profiles, e.g. with a previous known cardiovascular disease but without known AF.

摘要

目的

本研究旨在探讨伴有和不伴有记录在案的心房颤动(AF)的卒中患者的全因死亡率,以及 CHADS2 评分的影响。

设计

研究纳入了 105074 例患者,其中 31821 例(30.3%)伴有记录在案的 AF,73253 例(69.7%)不伴有记录在案的 AF。这些患者于 2001-2005 年在瑞典卒中登记处注册。死亡率数据从瑞典死因登记处获得。卒中前的 CHADS2 评分使用瑞典国家出院登记处进行评估。

结果

校正年龄和性别后,AF 患者的死亡相对风险(RR)为 1.46(1.43-1.49)。高年龄(≥75 岁)使死亡风险增加两倍,是最重要的单一预测因素,其次是充血性心力衰竭、既往卒中及糖尿病。在 CHADS2 评分为 1-6 的 AF 患者中,不到一半的患者存活时间超过 5 年,而 CHADS2 评分为 0 的 AF 患者的存活机会为 73%。在 AF 患者中,死亡的相对风险为 6.05(CI:2.26-6.95);在 CHADS2 评分最高和最低的患者中,相应的 RR 为非 AF 患者的 7.93(CI:7.01-8.97)。

结论

CHADS2 评分似乎对卒中后全因死亡率有影响。CHADS2 评分除了可以反映是否发生过缺血性卒中之外,还可以为其他预后变量提供有价值的信息,并且可以应用于具有不同危险因素谱的患者,例如有已知的心血管疾病但无已知的 AF。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验